|
PLK4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.59139995309965E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.70670000021467E-07 |
| Normal-vs-Stage2 |
2.187200E-04 |
| Normal-vs-Stage3 |
3.56700000000432E-05 |
| Normal-vs-Stage4 |
1.14289999997297E-06 |
| Stage1-vs-Stage2 |
9.498600E-01 |
| Stage1-vs-Stage3 |
8.167200E-01 |
| Stage1-vs-Stage4 |
1.795550E-02 |
| Stage2-vs-Stage3 |
9.130200E-01 |
| Stage2-vs-Stage4 |
4.186500E-02 |
| Stage3-vs-Stage4 |
4.138300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.31050001143052E-09 |
| Normal-vs-AfricanAmerican |
1.102090E-03 |
| Normal-vs-Asian |
1.478980E-01 |
| Caucasian-vs-AfricanAmerican |
6.457800E-02 |
| Caucasian-vs-Asian |
4.257200E-01 |
| AfricanAmerican-vs-Asian |
3.144200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.09229999489813E-08 |
| Normal-vs-Female |
6.13949999950236E-07 |
| Male-vs-Female |
5.506000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.784710E-03 |
| Normal-vs-Age(41-60Yrs) |
1.2582999975308E-08 |
| Normal-vs-Age(61-80Yrs) |
4.72039999976914E-07 |
| Normal-vs-Age(81-100Yrs) |
6.439500E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.586800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.364370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.242400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.705000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.872160E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.441700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.676300E-03 |
| Normal-vs-Grade 2 |
1.69600000043957E-07 |
| Normal-vs-Grade 3 |
2.13729999998247E-06 |
| Normal-vs-Grade 4 |
2.23619999999425E-05 |
| Grade 1-vs-Grade 2 |
7.392000E-01 |
| Grade 1-vs-Grade 3 |
4.960000E-01 |
| Grade 1-vs-Grade 4 |
1.992960E-01 |
| Grade 2-vs-Grade 3 |
3.582000E-01 |
| Grade 2-vs-Grade 4 |
5.780100E-02 |
| Grade 3-vs-Grade 4 |
2.615900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.41020000002479E-06 |
| Normal-vs-ccB subtype |
1.94830000022073E-07 |
| ccA subtype-vs-ccB subtype |
1.097750E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.12109999564447E-08 |
| Normal-vs-N1 |
4.900100E-03 |
| N0-vs-N1 |
1.007780E-01 |
|
|
